SCHEMBL1762881

SCHEMBL1762881

Cn1nc(C(F)F)c(C(N)=O)c1-c1ccccc1-c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.41
CSNK1E P49674 1/20 0.41
POLB P06746 1/20 0.38
DHODH Q02127 1/20 0.37
GRM2 Q14416 1/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
PRKD3 O94806 1/20 0.34
CLK2 P49760 1/20 0.34
DYRK1A Q13627 1/20 0.34
PRKD2 Q9BZL6 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
PARP1 P09874 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
AURKA O14965 1/20 0.33
CCNA2 P20248 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3329484 0.90 CSNK1D (0.41) CSNK1DCSNK1EPOLBDHODHGRM2
SCHEMBL1763226 0.90 CSNK1E (0.41) CSNK1DCSNK1EPOLBDHODHMAPT
SCHEMBL1762911 0.89 POLB (0.36) CSNK1DCSNK1EPOLBDHODHGRM2
SCHEMBL18691186 0.88 POLB (0.35) CSNK1DCSNK1EPOLBDHODHGRM2
SCHEMBL28930106 0.86 GRM2 (0.39) CSNK1DCSNK1EPOLBGRM2RAB9A
SCHEMBL1762849 0.86 HSD17B10 (0.44) CSNK1DCSNK1EPOLBGRM2KDM4E
SCHEMBL1763063 0.86 MGLL (0.38) CSNK1DCSNK1EPOLBDHODH
SCHEMBL1762883 0.84 POLB (0.38) CSNK1DCSNK1EPOLBDHODH
SCHEMBL27708025 0.84 SCN9A (0.40) CSNK1DCSNK1EPOLBPARP1CCNA2
SCHEMBL3209298 0.84 HSD17B10 (0.38) CSNK1DCSNK1EPOLBDHODHGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263327-B2 Enzymatic method for the production of microcapsules BASF SE (DE) 2012-09-11 US disclosed
US-20110124590-A1 Oil-in-Water Emulsion Comprising Solvent, Water, Surfactant and Pesticide BASF SE (DE) 2011-05-26 US disclosed
US-20100120617-A1 Enzymatic Method for the Production of Microcapsules BASF SE 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120617-A1 Enzymatic Method for the Production of Microcapsules MGAM, ACHE, BCHE CSNK1D 1071/4885CSNK1E 1043/4885POLB 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.